224 related articles for article (PubMed ID: 31904876)
1. Inhibition of glutaminase to reverse fibrosis in iatrogenic laryngotracheal stenosis.
Tsai HW; Motz KM; Ding D; Lina I; Murphy MK; Benner D; Feeley M; Hooper J; Hillel AT
Laryngoscope; 2020 Dec; 130(12):E773-E781. PubMed ID: 31904876
[TBL] [Abstract][Full Text] [Related]
2. Targeting metabolic abnormalities to reverse fibrosis in iatrogenic laryngotracheal stenosis.
Murphy MK; Motz KM; Ding D; Yin L; Duvvuri M; Feeley M; Hillel AT
Laryngoscope; 2018 Feb; 128(2):E59-E67. PubMed ID: 28940431
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.
Lina I; Tsai HW; Ding D; Davis R; Motz KM; Hillel AT
Laryngoscope; 2021 Jul; 131(7):1570-1577. PubMed ID: 32857885
[TBL] [Abstract][Full Text] [Related]
4. Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis.
Tsai HW; Lina I; Motz KM; Chung L; Ding D; Murphy MK; Feeley M; Elisseeff JH; Hillel AT
Laryngoscope; 2021 Jul; 131(7):E2125-E2130. PubMed ID: 33433011
[TBL] [Abstract][Full Text] [Related]
5. M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts.
Motz K; Lina I; Murphy MK; Drake V; Davis R; Tsai HW; Feeley M; Yin LX; Ding D; Hillel A
Laryngoscope; 2021 Feb; 131(2):E346-E353. PubMed ID: 33051870
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Epithelial Changes in Laryngotracheal Stenosis.
Lina IA; Tsai HW; Berges AJ; Ospino RA; Davis RJ; Motz KM; Collins S; Ghosh B; Sidhaye V; Gelbard A; Hillel AT
Laryngoscope; 2022 Nov; 132(11):2194-2201. PubMed ID: 35141889
[TBL] [Abstract][Full Text] [Related]
7. Fibroblasts in Hypoxic Conditions Mimic Laryngotracheal Stenosis.
Yin LX; Motz KM; Samad I; Duvvuri M; Murphy M; Ding D; Hillel AT
Otolaryngol Head Neck Surg; 2017 May; 156(5):886-892. PubMed ID: 28349784
[TBL] [Abstract][Full Text] [Related]
8. Identifying Phenotypically Distinct Fibroblast Subsets in Type 2 Diabetes-Associated Iatrogenic Laryngotracheal Stenosis.
Lina IA; Berges A; Ospino R; Davis RJ; Motz KM; Tsai HW; Collins S; Hillel AT
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):712-719. PubMed ID: 34126803
[TBL] [Abstract][Full Text] [Related]
9. Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate-mediated mTOR Activation and Proline Hydroxylation.
Ge J; Cui H; Xie N; Banerjee S; Guo S; Dubey S; Barnes S; Liu G
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):378-390. PubMed ID: 29019707
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.
Davis RJ; Lina I; Ding D; Engle EL; Taube J; Gelbard A; Hillel AT
Laryngoscope; 2021 May; 131(5):967-974. PubMed ID: 32557663
[TBL] [Abstract][Full Text] [Related]
11. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
12. Metabolic variations in normal and fibrotic human laryngotracheal-derived fibroblasts: A Warburg-like effect.
Ma G; Samad I; Motz K; Yin LX; Duvvuri MV; Ding D; Namba DR; Elisseeff JH; Horton MR; Hillel AT
Laryngoscope; 2017 Mar; 127(3):E107-E113. PubMed ID: 27585358
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.
Xiang Y; Stine ZE; Xia J; Lu Y; O'Connor RS; Altman BJ; Hsieh AL; Gouw AM; Thomas AG; Gao P; Sun L; Song L; Yan B; Slusher BS; Zhuo J; Ooi LL; Lee CG; Mancuso A; McCallion AS; Le A; Milone MC; Rayport S; Felsher DW; Dang CV
J Clin Invest; 2015 Jun; 125(6):2293-306. PubMed ID: 25915584
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.
Seltzer MJ; Bennett BD; Joshi AD; Gao P; Thomas AG; Ferraris DV; Tsukamoto T; Rojas CJ; Slusher BS; Rabinowitz JD; Dang CV; Riggins GJ
Cancer Res; 2010 Nov; 70(22):8981-7. PubMed ID: 21045145
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.
Shukla K; Ferraris DV; Thomas AG; Stathis M; Duvall B; Delahanty G; Alt J; Rais R; Rojas C; Gao P; Xiang Y; Dang CV; Slusher BS; Tsukamoto T
J Med Chem; 2012 Dec; 55(23):10551-63. PubMed ID: 23151085
[TBL] [Abstract][Full Text] [Related]
16. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
[TBL] [Abstract][Full Text] [Related]
17. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
McDonald CJ; Acheff E; Kennedy R; Taylor L; Curthoys NP
Neurochem Int; 2015 Sep; 88():10-4. PubMed ID: 25510640
[TBL] [Abstract][Full Text] [Related]
18. GLS2 is protumorigenic in breast cancers.
Dias MM; Adamoski D; Dos Reis LM; Ascenção CFR; de Oliveira KRS; Mafra ACP; da Silva Bastos AC; Quintero M; de G Cassago C; Ferreira IM; Fidelis CHV; Rocco SA; Bajgelman MC; Stine Z; Berindan-Neagoe I; Calin GA; Ambrosio ALB; Dias SMG
Oncogene; 2020 Jan; 39(3):690-702. PubMed ID: 31541193
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).
Robinson MM; McBryant SJ; Tsukamoto T; Rojas C; Ferraris DV; Hamilton SK; Hansen JC; Curthoys NP
Biochem J; 2007 Sep; 406(3):407-14. PubMed ID: 17581113
[TBL] [Abstract][Full Text] [Related]
20. T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.
Hillel AT; Ding D; Samad I; Murphy MK; Motz K
Laryngoscope; 2019 Jan; 129(1):177-186. PubMed ID: 30421427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
